NEXGEL, INC. Cost of Revenue
NEXGEL, INC. (NXGL) reported Cost of Revenue of $2.58 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-17
- NEXGEL, INC. cost of revenue for the quarter ending 2026-06-30 was $2.58M, a 58.49% increase year-over-year.
- NEXGEL, INC. cost of revenue for the quarter ending 2026-03-31 was $1.59M, a 1.79% decline year-over-year.
- NEXGEL, INC. cost of revenue for the quarter ending 2025-12-31 was $1.98M, a 0.51% increase year-over-year.
- NEXGEL, INC. cost of revenue for the quarter ending 2025-09-30 was $1.69M, a 5.27% decline year-over-year.
- NEXGEL, INC. cost of revenue for fiscal 2025 was $6.91M, a 16.36% increase from fiscal 2024.
- NEXGEL, INC. cost of revenue for fiscal 2024 was $5.94M, a 59.89% increase from fiscal 2023.
- NEXGEL, INC. cost of revenue for fiscal 2023 was $3.71M, a 107.31% increase from fiscal 2022.
- NEXGEL, INC. cost of revenue for fiscal 2022 was $1.79M, a 16.14% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.58M 10-Q · filed 2026-08-17 | $4.17M 10-Q · filed 2026-08-17 | $6.14M derived: sum of 3 quarters · filed 2026-08-17 | $7.83M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2026-03-31 | $1.59M 10-Q · filed 2026-05-14 | $3.57M derived: sum of 2 quarters · filed 2026-05-14 | $5.26M derived: sum of 3 quarters · filed 2026-05-14 | $6.88M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2025-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.67M derived: sum of 2 quarters · filed 2026-03-31 | $5.29M derived: sum of 3 quarters · filed 2026-08-17 | $6.91M 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $1.69M 10-Q · filed 2025-11-12 | $3.32M derived: sum of 2 quarters · filed 2026-08-17 | $4.93M 10-Q · filed 2025-11-12 | $6.90M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2025-06-30 | $1.63M 10-Q · filed 2026-08-17 | $3.24M 10-Q · filed 2026-08-17 | $5.21M derived: sum of 3 quarters · filed 2026-08-17 | $7.00M derived: sum of 4 quarters · filed 2026-08-17 | ||||
| 2025-03-31 | $1.62M 10-Q · filed 2026-05-14 | $3.58M derived: sum of 2 quarters · filed 2026-05-14 | $5.37M derived: sum of 3 quarters · filed 2026-05-14 | $6.52M derived: sum of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | $1.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.75M derived: sum of 2 quarters · filed 2026-03-31 | $4.90M derived: sum of 3 quarters · filed 2026-03-31 | $5.94M 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | $1.78M 10-Q · filed 2025-11-12 | $1.66M 10-Q · filed 2024-11-13 | $2.93M derived: sum of 2 quarters · filed 2025-11-12 | $3.97M 10-Q · filed 2025-11-12 | $3.68M 10-Q · filed 2024-11-13 | $5.21M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $1.15M 10-Q · filed 2025-08-12 | $1.03M 10-Q · filed 2024-08-19 | $2.19M 10-Q · filed 2025-08-12 | $2.02M 10-Q · filed 2024-08-19 | $3.42M derived: sum of 3 quarters · filed 2025-08-12 | $4.30M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $1.11M 10-Q · filed 2025-05-13 | $989.00K 10-Q · filed 2024-05-13 | $2.27M derived: sum of 2 quarters · filed 2025-05-13 | $3.15M derived: sum of 3 quarters · filed 2025-05-13 | $4.14M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.05M derived: sum of 2 quarters · filed 2025-03-27 | $3.04M derived: sum of 3 quarters · filed 2025-03-27 | $3.71M 10-K · filed 2025-03-27 | $3.47M 10-K · filed 2024-04-10 | |||
| 2023-09-30 | $877.00K 10-Q · filed 2024-11-13 | $1.87M derived: sum of 2 quarters · filed 2024-11-13 | $2.55M 10-Q · filed 2024-11-13 | $3.03M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $992.00K 10-Q · filed 2024-08-19 | $1.67M 10-Q · filed 2024-08-19 | $2.16M derived: sum of 3 quarters · filed 2024-08-19 | $2.58M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2023-03-31 | $677.00K 10-Q · filed 2024-05-13 | $1.17M derived: sum of 2 quarters · filed 2024-05-13 | $1.58M derived: sum of 3 quarters · filed 2024-05-13 | $2.04M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $488.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $908.00K derived: sum of 2 quarters · filed 2024-04-10 | $1.37M derived: sum of 3 quarters · filed 2024-04-10 | $1.79M 10-K · filed 2024-04-10 | ||||
| 2022-09-30 | $420.00K 10-Q · filed 2023-11-13 | $880.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.30M 10-Q · filed 2023-11-13 | $1.73M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $460.00K 10-Q · filed 2023-08-14 | $884.00K 10-Q · filed 2023-08-14 | $1.31M derived: sum of 3 quarters · filed 2023-08-14 | $1.70M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $418.00K 10-Q · filed 2023-05-15 | $848.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.24M derived: sum of 3 quarters · filed 2023-05-15 | $1.65M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $430.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $822.00K derived: sum of 2 quarters · filed 2023-03-28 | $1.24M derived: sum of 3 quarters · filed 2023-03-28 | $1.54M 10-K · filed 2023-03-28 | $1.54M 10-K · filed 2022-03-21 | |||
| 2021-09-30 | $392.00K 10-Q · filed 2022-11-08 | $805.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.11M 10-Q · filed 2022-11-08 | $1.35M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $413.00K 10-Q · filed 2022-08-10 | $722.00K 10-Q · filed 2022-08-10 | $961.00K derived: sum of 3 quarters · filed 2022-08-10 | $1.23M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $309.00K 10-Q · filed 2022-05-13 | $548.00K derived: sum of 2 quarters · filed 2022-05-13 | $817.00K derived: sum of 3 quarters · filed 2022-05-13 | $993.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $508.00K derived: sum of 2 quarters · filed 2022-03-21 | $684.00K derived: sum of 3 quarters · filed 2022-03-21 | $965.00K 10-K · filed 2022-03-21 | ||||
| 2020-09-30 | $269.00K 10-Q · filed 2021-11-10 | $210.00K 10-Q · filed 2020-11-16 | $445.00K derived: sum of 2 quarters · filed 2021-11-10 | $726.00K 10-Q · filed 2021-11-10 | $559.00K 10-Q · filed 2020-11-16 | $831.00K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $176.00K 10-Q · filed 2021-08-16 | $349.00K 10-Q · filed 2021-08-16 | $562.00K derived: sum of 3 quarters · filed 2021-08-16 | $775.00K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $173.00K 10-Q · filed 2021-05-17 | $386.00K derived: sum of 2 quarters · filed 2021-05-17 | $599.00K derived: sum of 3 quarters · filed 2021-05-17 | $790.00K derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $426.00K derived: sum of 2 quarters · filed 2021-03-31 | $617.00K derived: sum of 3 quarters · filed 2021-03-31 | $854.00K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $213.00K 10-Q · filed 2020-11-16 | $404.00K derived: sum of 2 quarters · filed 2020-11-16 | $641.00K 10-Q · filed 2020-11-16 | $1.01M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $191.00K 10-Q · filed 2020-08-14 | $428.00K 10-Q · filed 2020-08-14 | $799.00K derived: sum of 3 quarters · filed 2020-08-14 | $1.16M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $237.00K 10-Q · filed 2020-05-14 | $608.00K derived: sum of 2 quarters · filed 2020-05-14 | $966.00K derived: sum of 3 quarters · filed 2020-05-14 | $1.54M derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $371.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-04-03 | $729.00K derived: sum of 2 quarters · filed 2020-04-03 | $1.31M derived: sum of 3 quarters · filed 2020-04-03 | $1.70M 10-K/A · filed 2020-04-03 | ||||
| 2018-09-30 | $358.00K 10-Q · filed 2020-01-28 | $937.00K derived: sum of 2 quarters · filed 2020-01-28 | $1.33M 10-Q · filed 2020-01-28 | |||||
| 2018-06-30 | $579.00K 10-Q · filed 2019-09-09 | $993.00K 10-Q · filed 2019-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |